Ibuprofen guaiacol ester (AF 2259, Metoxibutropate) is an orally active mutual prodrug of Ibuprofen (HY-78131) and Guaiacol (HY-N1380), designed to reduce the gastrointestinal (GI) side effects of ibuprofen. Ibuprofen guaiacol ester inhibits the synthesis of prostaglandin. Ibuprofen guaiacol ester inherits the antipyretic, analgesic and anti-inflammatory properties of Ibuprofen and Guaiacol, but reduces gastric damage. Ibuprofen guaiacol ester can be used to alleviate gastric erosion/ulcers induced by classic anti-inflammatory agent (such as Ibuprofen)[1][2].
Molecular Weight:
312.40
Purity:
98.49
CAS Number:
[66332-77-2]
Formula:
C20H24O3
Target:
Prostaglandin Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted